Ammonia metabolism and hyperammonemic disorders

Area of Science:

• Human physiology
• Biochemistry
• Neuroscience

Background:

• Humans produce ~1000 mmol of ammonia daily, a portion of which is neurotoxic waste.
• Ammonia is detoxified via urea production, glutamine synthesis, and metabolism in the kidneys and intestine.
• Faulty ammonia metabolism leads to hyperammonemia, causing encephalopathy and potential brain damage.

Purpose of the Study:

• To review the complex pathways of ammonia metabolism and detoxification in humans.
• To discuss the mechanisms of ammonia neurotoxicity and hyperammonemia-induced brain edema.
• To highlight the clinical significance of hyperammonemia in liver disease and inherited metabolic disorders.

Main Methods:

• Review of established knowledge on ammonia metabolism.
• Integration of findings from molecular biology, NMR imaging, and spectroscopy.
• Analysis of clinical presentations and proposed pathomechanisms of hyperammonemia.

Main Results:

• Ammonia detoxification involves ureagenesis in the liver and glutamine synthesis in extrahepatic tissues.
• Hyperammonemia results in astrocyte swelling and multifactorial neurotoxicity, affecting neurotransmitters, energy metabolism, and ion balance.
• Liver disease accounts for most hyperammonemia cases, while inherited defects are less common but increasingly recognized in adults.

Conclusions:

• Ammonia metabolism is a finely tuned process crucial for preventing neurotoxicity.
• Hyperammonemia, particularly in liver disease, poses significant risks for acute and chronic neurological impairment.
• Understanding ammonia pathways is vital for managing hyperammonemic conditions, with therapeutic agents like phenylbutyrate showing promise.